Concepedia

Emily S. Magnavita

ES

5

Publications

113

Citations

5

H-Index

2020

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Emily S. Magnavita is an author at Dana-Farber Cancer Institute specializing in medicine, outcomes research, and oncology.

Top concepts

Publications per year

2020–2021

5

Publications

5

Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies

Clark DuMontier, Hajime Uno, Tammy T. Hshieh et al. · Haematologica · 2021 · 53 citations · Full text

, , +20

Prevalence and Tolerance of Prognostic Uncertainty Among Thoracic Oncologists

Anand Habib, Richard Chen, Emily S. Magnavita et al. · The Oncologist · 2021 · 19 citations · Full text

, , +13

Peri‐transfusion quality‐of‐life assessment for patients with myelodysplastic syndromes

Gregory A. Abel, Heidi D. Klepin, Emily S. Magnavita et al. · Transfusion · 2021 · 15 citations

US State Government Crisis Standards of Care Guidelines

Andrew Hantel, Jonathan M. Marron, Michael Casey et al. · JAMA Oncology · 2020 · 14 citations · Full text

Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions

Anna Tanasijevic, Anna Revette, Heidi D. Klepin et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 12 citations

, , +15

Rows per page

1–5 of 5